Giuseppe Ciaramella, President at Beam Therapeutics Inc. (BEAM), sold 14,868 shares at $18.35 ($273K) on 2025-04-01, disclosed to the SEC on 2025-04-03.
Scheduled sale ($273k) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.35 | 7,434 | $136K | 50.0% |
| 2 | $18.35 | 7,434 | $136K | 50.0% |
| Total | $18.35 avg | 14,868 | $273K | 100% |
| Filing → |
| BEAM | SELL | 2024-11-08 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-10-16 | $2.7M | — | Filing → |
| BEAM | SELL | 2024-04-03 | $291K | — | Filing → |